Analysts' ratings for IDEXX Laboratories (NASDAQ:IDXX) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table summarizes their recent ratings, shedding ...
Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...
Revenue for Q4 2024 was reported at $954 million, surpassing the estimate of $935 million. Q4 EPS came in at $2.62, exceeding the anticipated $2.40. The Companion Animal Group diagnostics segment ...
IDEXX Laboratories missed estimated earnings by -0.0%, reporting an EPS of $2.92 versus an estimate of $2.93. Revenue was up $136.71 million from the same period last year. During the previous quarter ...
Zacks Investment Research on MSN
Why is Idexx (IDXX) up 0.5% since last earnings report?
It has been about a month since the last earnings report for Idexx Laboratories (IDXX). Shares have added about 0.5% in that time frame, outperforming the S&P 500. But investors have to be wondering, ...
We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the ...
Hosted on MSN
Leerink Raises PT on IDEXX Laboratories (IDXX) Stock
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the Best Stocks to Buy According to Brasada Capital Management. On July 17, Leerink analyst Daniel Clark lifted the company’s price objective to $600 ...
Feb 2 (Reuters) - Animal diagnostics maker IDEXX Laboratories (IDXX.O), opens new tab forecast 2026 revenue and profit slightly above Wall Street estimates on Monday, but said veterinary clinic visits ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
Seilern sold 70,900 shares of IDEXX Laboratories; estimated transaction value of approximately $43.03 million. The sale represents a 3.11% change relative to the fund’s 13F AUM. Post-trade holding: ...
IDEXX Laboratories, Inc. IDXX is set to release third-quarter 2025 results on Nov. 3, before the opening bell. In the last reported quarter, the company posted adjusted earnings per share (EPS) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results